News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Enyedy Mark J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Sold 986,521 shares
@ $17.45, valued at
$17.2M
Sold 8,636 shares
@ $18.15, valued at
$156.7k
Sold 1,020,000 shares
@ $16.61, valued at
$16.9M
Sold 992,397 shares
@ $16.96, valued at
$16.8M
Exercised 995,157 options to buy
@ $4.55, valued at
$4.5M
Exercised 2,760 options to buy
@ $5.25, valued at
$14.5k
Exercised 831,147 options to buy
@ $4.55, valued at
$3.8M
Exercised 186,093 options to buy
@ $4.55, valued at
$846.7k
Exercised 300,000 options to buy
@ $5.65, valued at
$1.7M
Exercised 782,240 options to buy
@ $5.25, valued at
$4.1M
Exercised 21,978 options to buy
@ $4.55, valued at
$100k
|
|
| 08/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 5,241 shares
@ $4.05, valued at
$21.2k
|
|
| 02/07/2023 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 153,700 restricted stock units
@ $0
Granted 922,400 options to buy
@ $4.66, valued at
$4.3M
|
|
| 12/27/2022 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 393,750 options to buy
@ $4.55, valued at
$1.8M
Granted 787,500 options to buy
@ $4.55, valued at
$3.6M
|
|
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,849 shares
@ $5.52, valued at
$21.2k
|
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| Enyedy Mark J (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 03/19/2020 |
4
| Enyedy Mark J (Director) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.34, valued at
$106.8k
|
|
| 03/19/2020 |
3
| Enyedy Mark J (Director) has filed a Form 3 on LogicBio Therapeutics, Inc. |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 5,230 shares
@ $1.84, valued at
$9.6k
|
|
| 06/10/2019 |
4
| Enyedy Mark J (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 2,455 shares
@ $4.08, valued at
$10k
|
|
| 12/13/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 3,743 shares
@ $0
Granted 18,716 options to buy
@ $19.56, valued at
$366.1k
Granted 11,229 options to buy
@ $10.05, valued at
$112.9k
Granted 25,000 options to buy
@ $8.94, valued at
$223.5k
|
|
| 12/13/2018 |
3
| Enyedy Mark J (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,000 shares
@ $0
Disposed/sold 80,000 options
@ $0 |
|
| 07/12/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $3.76, valued at
$112.8k
|
|
| 02/23/2018 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Sold 67,717 shares
@ $10.87, valued at
$736.1k
|
|
| 02/20/2018 |
4
| Enyedy Mark J (CEO) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 1,100,000 options to buy
@ $10.65, valued at
$11.7M
|
|
| 09/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|